1. Home
  2. JANX vs RCAT Comparison

JANX vs RCAT Comparison

Compare JANX & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$18.05

Market Cap

975.7M

Sector

Health Care

ML Signal

HOLD

Logo Red Cat Holdings Inc.

RCAT

Red Cat Holdings Inc.

HOLD

Current Price

$8.47

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
JANX
RCAT
Founded
2017
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Wholesale Distributors
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
975.7M
1.1B
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
JANX
RCAT
Price
$18.05
$8.47
Analyst Decision
Buy
Strong Buy
Analyst Count
13
2
Target Price
$47.00
$20.00
AVG Volume (30 Days)
670.8K
8.8M
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,000,000.00
$17,836,382.00
Revenue This Year
N/A
$271.60
Revenue Next Year
N/A
$41.21
P/E Ratio
N/A
N/A
Revenue Growth
N/A
79.95
52 Week Low
$12.12
$5.77
52 Week High
$35.34
$18.78

Technical Indicators

Market Signals
Indicator
JANX
RCAT
Relative Strength Index (RSI) 68.29 45.44
Support Level $13.13 $8.61
Resistance Level $35.34 $8.85
Average True Range (ATR) 0.64 0.67
MACD 0.20 -0.11
Stochastic Oscillator 82.07 2.78

Price Performance

Historical Comparison
JANX
RCAT

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Its suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities. The firm's Division includes Teal, FlightWave, and Blue Ops.

Share on Social Networks: